NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$15.21
+27.49% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.6M
Novocure Ltd (NVCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.36M | $15.49M | $33.09M | $82.89M | $177.03M | $248.07M | $351.32M | $494.37M | $535.03M | $537.84M | $509.34M | $605.22M | $655.35M |
| Revenue growth (YoY) | — | +49.5% | +113.6% | +150.5% | +113.6% | +40.1% | +41.6% | +40.7% | +8.2% | +0.5% | -5.3% | +18.8% | +8.3% |
| Cost of revenue | $7.01M | $10.04M | $20.61M | $46.28M | $55.61M | $80.05M | $88.61M | $106.50M | $114.88M | $114.87M | $128.28M | $137.18M | $166.88M |
| Gross profit | $3.35M | $5.45M | $12.48M | $36.61M | $121.42M | $168.02M | $262.71M | $387.87M | $420.15M | $422.97M | $381.06M | $468.04M | $488.47M |
| Gross margin | 32.3% | 35.2% | 37.7% | 44.2% | 68.6% | 67.7% | 74.8% | 78.5% | 78.5% | 78.6% | 74.8% | 77.3% | 74.5% |
| R&D | $34.80M | $40.38M | $43.75M | $41.47M | $38.10M | $50.57M | $79.00M | $132.01M | $201.30M | $206.09M | $223.06M | $209.65M | $224.54M |
| SG&A | $16.60M | $24.05M | $33.86M | $51.01M | $59.11M | $73.46M | $87.95M | $107.44M | $126.13M | $132.75M | $164.06M | $189.83M | $177.67M |
| Operating income | $-64.46M | $-80.16M | $-104.00M | $-115.32M | $-39.33M | $-33.67M | $-914000.00 | $30.40M | $-44.33M | $-89.52M | $-232.87M | $-170.50M | $-153.80M |
| Operating margin | -622.3% | -517.5% | -314.3% | -139.1% | -22.2% | -13.6% | -0.3% | 6.1% | -8.3% | -16.6% | -45.7% | -28.2% | -23.5% |
| EBITDA | $-63.13M | $-78.19M | $-100.84M | $-109.67M | $-31.65M | $-24.67M | $7.55M | $44.83M | $-34.08M | $-78.90M | $-177.45M | $-109.58M | $-119.05M |
| EBITDA margin | -609.5% | -504.8% | -304.8% | -132.3% | -17.9% | -9.9% | 2.1% | 9.1% | -6.4% | -14.7% | -34.8% | -18.1% | -18.2% |
| EBIT | $-64.35M | $-80.16M | $-104.00M | $-115.32M | $-39.33M | $-33.67M | $-914000.00 | $35.68M | $-44.33M | $-89.52M | $-188.42M | $-120.82M | $-136.25M |
| Interest expense | $12.67M | $183000.00 | $2.37M | $5.94M | $10.26M | $13.49M | $13.72M | $18.05M | $3.44M | $3.33M | $4.91M | $11.66M | $17.04M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-77.37M | $-80.68M | $-111.58M | $-131.84M | $-61.66M | $-63.56M | $-7.23M | $19.81M | $-58.35M | $-92.53M | $-207.04M | $-168.63M | $-136.23M |
| Net income growth (YoY) | — | -4.3% | -38.3% | -18.2% | +53.2% | -3.1% | +88.6% | +374.0% | -394.6% | -58.6% | -123.7% | +18.6% | +19.2% |
| Profit margin | -746.9% | -520.9% | -337.2% | -159.1% | -34.8% | -25.6% | -2.1% | 4.0% | -10.9% | -17.2% | -40.6% | -27.9% | -20.8% |